chr2-178536160-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001267550.2(TTN):c.100587G>A(p.Trp33529*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,613,438 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001267550.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.100587G>A | p.Trp33529* | stop_gained | Exon 357 of 363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.100587G>A | p.Trp33529* | stop_gained | Exon 357 of 363 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152094Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461344Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 726944
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152094Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74278
ClinVar
Submissions by phenotype
not provided Pathogenic:2
TTN: PVS1:Strong, PM2 -
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Located in the A-band, a region of TTN for which truncating variants are significantly associated with autosomal dominant cardiomyopathy and also with autosomal recessive skeletal myopathies; This variant is associated with the following publications: (PMID: 33226272, 30535219, 34495297, 33906374, 29691892, 22335739, 32778822) -
TTN-related disorder Pathogenic:1
The TTN c.100587G>A variant is predicted to result in premature protein termination (p.Trp33529*). This variant has been reported in patients with TTN-related conditions (Ware et al. 2021. PubMed ID: 33906374; Choi et al. 2018. PubMed ID: 30535219). This variant is reported in 0.013% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is located in the A-Band and RNAseq studies from heart tissue indicate this exon is commonly included in TTN mRNA transcripts, demonstrating its clinical relevance (PSI of 100%, Roberts A.M. et al. 2015. PMID: 25589632; https://cardiodb.org/titin/titin_transcripts.php). Nonsense variants in this region of TTN are expected to be pathogenic. In the heterozygous state, early termination changes in the vicinity typically contribute to autosomal dominant cardiac-related phenotypes, whereas in combination with a second pathogenic variant in trans, they are associated with autosomal recessive muscular dystrophy phenotypes (Savarese et al. 2018. PubMed ID: 29435569). This variant is interpreted as pathogenic. -
Autosomal recessive limb-girdle muscular dystrophy type 2J Pathogenic:1
- -
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Pathogenic:1
This sequence change creates a premature translational stop signal (p.Trp33529*) in the TTN gene. While this is not anticipated to result in nonsense mediated decay, it is expected to create a truncated TTN protein. This variant is present in population databases (no rsID available, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with clinical features of TTN-related conditions (PMID: 30535219, 33226272, 33906374, 34495297; internal data). This variant is also known as c.92883G>A (p.W30961X). ClinVar contains an entry for this variant (Variation ID: 418978). This variant is located in the A band of TTN (PMID: 25589632). Truncating variants in this region are significantly overrepresented in patients affected with dilated cardiomyopathy (PMID: 25589632). Truncating variants in this region have also been reported in individuals affected with autosomal recessive centronuclear myopathy (PMID: 23975875). For these reasons, this variant has been classified as Pathogenic. -
Dilated cardiomyopathy 1G Pathogenic:1
- -
Early-onset myopathy with fatal cardiomyopathy Pathogenic:1
- -
Hypertrophic cardiomyopathy 9 Pathogenic:1
- -
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1838244:Tibial muscular dystrophy;C1858763:Dilated cardiomyopathy 1G;C1861065:Hypertrophic cardiomyopathy 9;C1863599:Myopathy, myofibrillar, 9, with early respiratory failure;C2673677:Early-onset myopathy with fatal cardiomyopathy Pathogenic:1
- -
Myopathy, myofibrillar, 9, with early respiratory failure Pathogenic:1
- -
Tibial muscular dystrophy Pathogenic:1
- -
Cardiovascular phenotype Pathogenic:1
The p.W24464* variant (also known as c.73392G>A), located in coding exon 184 of the TTN gene, results from a G to A substitution at nucleotide position 73392. This changes the amino acid from a tryptophan to a stop codon within coding exon 184. This exon is located in the A-band region of the N2-B isoform of the titin protein and is constitutively expressed in TTN transcripts (percent spliced in or PSI 100%). This alteration, also referred to as p.Trp33529* c.100587G>A , has been detected in an atrial fibrillation cohort and was reported to co-occur in trans with a TTN canonical I-band variant in a case with pediatric-onset cardiomyopathy from a cohort of patients with early onset hypotonia and/or congenital contractures (Choi SH et al. JAMA, 2018 12;320:2354-2364; Oates EC. Ann Neurol. 2018 Jun;83(6):1105-1124). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. While truncating variants in TTN are present in 1-3% of the general population, truncating variants in the A-band are the most common cause of dilated cardiomyopathy (DCM) (Herman DS et al. N. Engl. J. Med., 2012 Feb;366:619-28; Roberts AM et al. Sci Transl Med, 2015 Jan;7:270ra6). TTN truncating variants encoded in constitutive exons (PSI >90%) have been found to be significantly associated with DCM regardless of their position in titin (Schafer S et al. Nat. Genet., 2017 01;49:46-53). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at